This information was confirmed by several sources of PhV.
According to some market players, the negotiations on the acquisition of the republican chain 36.6 (Kazan) by the pharmacy chain Pharmland were held during the last month.
Artur Urazmanov, General Director of the republican chain 36.6 declined to comment, while the owner of the business and the Chairman of the Board of Pharmland Oleg Murov promised to answer PhV’s questions later.
Based on the results of the first half of 2017, Pharmland ranks 9th in the rating of pharmacy chains. Pharmland has the market share of 1.68%; total sales for the 1st half of 2017 amount to 9,252.49 million rubles; the company is represented in 7 regions, with 758 outlets. The Republican chain 36.6 (Kazan) ranks 63rd, with a market share of 0.19%; 1,027.39 million rubles of total sales for the 1st half of 2017:; it is represented in 3 regions with 99 points. Based on the results of the transaction, we can expect that the pharmacy chain Pharmland will rise to the 8th line in the rating of pharmacy chains ", explained the deputy general director of the analytical company Alpharm, Tatyana Litvinova.
The details of the deal were not disclosed. However, the fact that the owner of Kazan’s 36.6 was interested in this transaction surprised the analysts. According to Sergey Shulyak, CEO of DSM Group, Arthur Urazmanov has no apparent reason for selling his chain.
“The asset is good, strong, and stable. The working process runs well. I would consider this chain as exemplary. There are no visible negative reasons for the sale,” said the analyst.
This deal is definitely profitable for Pharmland, for any company is interested in growing, the experts explain.
At one of the industry’s events, at the end of 2016, Oleg Murov stated that he was interested in merger-acquisition transactions.
“We acquired approximately 150 pharmacies through mergers and acquisitions. It can not be said that this is our general strategy; it was just written in the stars,” the businessman commented on the results of the period from September 2015 to September 2016.
Moreover, at the end of 2016, the company announced its plans to actively enter the neighboring regions.
“There is just one principle of entering other regions, and we are not going to change it: we enter the neighboring regions. The regions that are located within one day’s car ride are the best. We still keep our business well centered: all the management decisions are made in the head office,” Oleg Murov explained.
This information was confirmed by several sources of PhV.
According to some market players, the negotiations on the acquisition of the republican chain 36.6 (Kazan) by the pharmacy chain Pharmland were held during the last month.
Artur Urazmanov, General Director of the republican chain 36.6 declined to comment, while the owner of the business and the Chairman of the Board of Pharmland Oleg Murov promised to answer PhV’s questions later.
Based on the results of the first half of 2017, Pharmland ranks 9th in the rating of pharmacy chains. Pharmland has the market share of 1.68%; total sales for the 1st half of 2017 amount to 9,252.49 million rubles; the company is represented in 7 regions, with 758 outlets. The Republican chain 36.6 (Kazan) ranks 63rd, with a market share of 0.19%; 1,027.39 million rubles of total sales for the 1st half of 2017:; it is represented in 3 regions with 99 points. Based on the results of the transaction, we can expect that the pharmacy chain Pharmland will rise to the 8th line in the rating of pharmacy chains ", explained the deputy general director of the analytical company Alpharm, Tatyana Litvinova.
The details of the deal were not disclosed. However, the fact that the owner of Kazan’s 36.6 was interested in this transaction surprised the analysts. According to Sergey Shulyak, CEO of DSM Group, Arthur Urazmanov has no apparent reason for selling his chain.
“The asset is good, strong, and stable. The working process runs well. I would consider this chain as exemplary. There are no visible negative reasons for the sale,” said the analyst.
This deal is definitely profitable for Pharmland, for any company is interested in growing, the experts explain.
At one of the industry’s events, at the end of 2016, Oleg Murov stated that he was interested in merger-acquisition transactions.
“We acquired approximately 150 pharmacies through mergers and acquisitions. It can not be said that this is our general strategy; it was just written in the stars,” the businessman commented on the results of the period from September 2015 to September 2016.
Moreover, at the end of 2016, the company announced its plans to actively enter the neighboring regions.
“There is just one principle of entering other regions, and we are not going to change it: we enter the neighboring regions. The regions that are located within one day’s car ride are the best. We still keep our business well centered: all the management decisions are made in the head office,” Oleg Murov explained.
Read more: https://www.pharmvestnik.ru/publs/lenta/v-rossii/aptechnaja-setj-farmlend-kupila-kazanskuju-respublikanskuju-setj-36-6.html